We are live on ! Find out more
DCLA

Douglas C. Lane & Associates Portfolio holdings

AUM $3.69B
1-Year Est. Return 0.11%
This Fund
S&P 500
This Quarter Est. Return
+8.1%
1 Year Est. Return
+0.11%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.7B
AUM Growth
+$353M
Cap. Flow
+$108M
Cap. Flow %
2.9%
Top 10 Hldgs %
21.6%
Holding
250
New
17
Increased
88
Reduced
111
Closed
12

Sector Composition

Rank Sector Weight
1 Industrials 21.15%
2 Technology 15.87%
3 Healthcare 14.75%
4 Consumer Discretionary 11.03%
5 Financials 6.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESRX
151
DELISTED
Express Scripts Holding Company
ESRX
$800K 0.02%
9,443
+1,259
+15% +$98.4K
BA icon
152
Boeing
BA
$183B
$792K 0.02%
6,096
-2,307
-27% -$293K
KMB icon
153
Kimberly-Clark
KMB
$36.3B
$768K 0.02%
6,651
-1,301
-16% -$144K
TDG icon
154
TransDigm Group
TDG
$67.5B
$755K 0.02%
3,845
+150
+4% +$28.3K
HD icon
155
Home Depot
HD
$352B
$678K 0.02%
6,460
+68
+1% +$6.61K
AMZN icon
156
Amazon
AMZN
$2.98T
$628K 0.02%
40,460
+1,860
+5% +$29K
EPD icon
157
Enterprise Products Partners
EPD
$82.5B
$602K 0.02%
16,660
+10,860
+187% +$402K
JCI icon
158
Johnson Controls International
JCI
$92.9B
$575K 0.02%
11,365
-14,412
-56% -$704K
HSY icon
159
Hershey
HSY
$36.8B
$560K 0.02%
5,385
-1,715
-24% -$167K
BDX icon
160
Becton Dickinson
BDX
$48.4B
$550K 0.01%
4,049
+595
+17% +$76.1K
C icon
161
Citigroup
C
$225B
$518K 0.01%
9,577
-1,353
-12% -$71.8K
CVS icon
162
CVS Health
CVS
$122B
$509K 0.01%
5,286
+333
+7% +$29.3K
CDK
163
DELISTED
CDK Global, Inc.
CDK
$509K 0.01%
+12,488
New +$442K
EMC
164
DELISTED
EMC CORPORATION
EMC
$505K 0.01%
16,989
+1,835
+12% +$53.4K
MRSH
165
Marsh
MRSH
$91.5B
$501K 0.01%
8,750
-3,675
-30% -$202K
ZBH icon
166
Zimmer Biomet
ZBH
$18.3B
$501K 0.01%
4,548
DD
167
DELISTED
Du Pont De Nemours E I
DD
$493K 0.01%
7,018
-786
-10% -$52.5K
WBC
168
DELISTED
WABCO HOLDINGS INC.
WBC
$490K 0.01%
4,680
BAC icon
169
Bank of America
BAC
$440B
$468K 0.01%
26,144
+4,390
+20% +$75.1K
NEE icon
170
NextEra Energy
NEE
$178B
$443K 0.01%
16,688
-2,328
-12% -$58.8K
UL icon
171
Unilever
UL
$136B
$438K 0.01%
9,616
-1,984
-17% -$91K
GWW icon
172
W.W. Grainger
GWW
$60.3B
$427K 0.01%
1,674
BIIB icon
173
Biogen
BIIB
$30.4B
$426K 0.01%
1,255
+15
+1% +$4.85K
MCD icon
174
McDonald's
MCD
$195B
$424K 0.01%
4,528
-1,301
-22% -$122K
MMP
175
DELISTED
Magellan Midstream Partners, L.P.
MMP
$413K 0.01%
+5,000
New +$409K

Similar funds

Douglas C. Lane & Associates's Q4 2014 Portfolio in Review

As of Q4 2014, Douglas C. Lane & Associates held 250 positions worth $3.7B, up 11% from $3.35B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Douglas C. Lane & Associates's Q4 2014 filing shows 17 new, 88 increased, 111 reduced and 12 closed positions. Its largest new stake was Manhattan Associates: 267,887 shares worth $10.9M. The largest sale was Gen Digital, an estimated $14M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.

  • Douglas C. Lane & Associates's largest Q4 2014 buy was Manhattan Associates: 267,887 shares worth $10.9M.
  • Douglas C. Lane & Associates added most to Stratasys in Q4 2014, an estimated $34.7M increase.
  • Douglas C. Lane & Associates's biggest Q4 2014 reduction was Gen Digital, cutting an estimated $14M.
  • Douglas C. Lane & Associates fully exited Baxter International in Q4 2014, selling an estimated $343K.
  • Douglas C. Lane & Associates's ten largest holdings make up 22% of its $3.7B portfolio in Q4 2014.
  • Douglas C. Lane & Associates opened 17 new positions and closed 12 in Q4 2014.
  • Douglas C. Lane & Associates's portfolio value rose 11% quarter-over-quarter to $3.7B.

Based on Douglas C. Lane & Associates's 13F filing for Q4 2014, filed 21 Jan 2015.